Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-227563
Filing Date
2025-10-02
Accepted
2025-10-02 09:01:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d68795d424b3.htm 424B3 23470
2 GRAPHIC g68795g1002014916310.jpg GRAPHIC 3369
  Complete submission text file 0001193125-25-227563.txt   29543
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-284606 | Film No.: 251367158
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)